Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.balaxipharma.in | |
Market Cap | 557.02 Cr. | |
Enterprise Value(EV) | 559.28 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 49.67 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 11.01 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.87 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 156.37 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 3.50 | Calculated using Price: 547.10 |
Dividend Yield | 0.09 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.02 Cr. | 10,181,250 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products |
1 Day |
|
+0.25% |
1 Week |
|
+0.18% |
1 Month |
|
+0.20% |
3 Month |
|
-5.38% |
6 Month |
|
-5.69% |
1 Year |
|
+37.67% |
2 Year |
|
+0.04% |
5 Year |
|
+3596.62% |
10 Year |
|
4 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 55.84 | 39.04 | 82.26 | 53.50 | |
Return on Capital Employed (%) | 69.35 | 56.56 | 92.56 | 59.62 | |
Return on Assets (%) | 32.19 | 29.01 | 56.23 | 34.52 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 4 | 28 | 65 | 113 | 149 | |
Non Curr. Liab. | 0 | 0 | 1 | |||
Curr. Liab. | 3 | 8 | 35 | 63 | 50 | |
Minority Int. | ||||||
Equity & Liab. | 6 | 36 | 100 | 176 | 199 | |
Non Curr. Assets | 0 | 1 | 6 | 35 | 45 | |
Curr. Assets | 6 | 35 | 94 | 141 | 155 | |
Misc. Exp. not W/O | ||||||
Total Assets | 6 | 36 | 100 | 176 | 199 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 14 | 46 | 231 | 279 | 345 | |
Other Income | 1 | 1 | 2 | 5 | 7 | |
Total Income | 14 | 46 | 234 | 284 | 352 | |
Total Expenditure | -12 | -37 | -189 | -229 | -290 | |
PBIDT | 2 | 9 | 45 | 56 | 62 | |
Interest | 0 | 0 | -1 | 0 | ||
Depreciation | 0 | 0 | -1 | -1 | ||
Taxation | 0 | -3 | -6 | -7 | -10 | |
Exceptional Items | ||||||
PAT | 2 | 6 | 38 | 48 | 51 | |
Minority Interest | ||||||
Share Associate | ||||||
Other Related Items | -1 | 1 | ||||
Consolidated Net Profit | 2 | 6 | 37 | 48 | 51 | |
Adjusted EPS | 6 | 6 | 37 | 48 | 51 |
Particulars | 4 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -2 | -14 | 34 | ||
Cash Fr. Inv. | 0 | 0 | -6 | -28 | |
Cash Fr. Finan. | 18 | 4 | 0 | ||
Net Change | -2 | 4 | -2 | 6 | |
Cash & Cash Eqvt | 0 | 4 | 2 | 7 |
Wed, 15 Mar 2023
Allotment of Securities
|
|
Tue, 14 Mar 2023
Allotment of Securities
|
|
Fri, 10 Mar 2023
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
|
Fri, 24 Mar 2023 |
|
|
|
|
|